People on GLP-1 drugs report fewer alcohol cravings, and KTSM says the drugs' popularity is now becoming a challenge for brewers.
Recap by typeshit. Post by @ktsmtv on Instagram.
CNBC's investing team lifts its target on Lilly shares and argues the obesity drug run still has room to grow.
The Pharma Letter looks at how semaglutide generics are changing strategy in India, with Torrent eyeing an expansion into Brazil.
Semafor looks at how little national political figures have said about what the new class of weight loss drugs means for policy.
The doctors take on two of the topics their followers ask about most, giving their verdict on statins and Ozempic.
A retrospective matched study of 16,792 type 2 diabetes patients linked prior GLP-1 drug use to lower mortality from necrotizing soft tissue infection.
Western Isles prescribes at 10 times Shetland's rate, and 71% of Scots who used weight loss drugs in the past year got them privately, the ABPI reports.
Loading…